3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
13
Rectal Neoplasms
4
Neoplasm Metastasis
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumors
2
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma, Ewing
1
Sarcoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Microsatellite-stable Colorectal Cancer
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Advanced Microsatellite Stable Colorectal Cancer
1
Adenomatous Polyposis Coli
1
Interventions
Gemcitabine
15
Cisplatin
13
durvalumab
12
pembrolizumab
10
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Biopsy
7
Specimen Handling
6
Leucovorin
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
futibatinib
3
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
lenvatinib
2
fludarabine
2
dehydroftorafur
2
Radiation Dose Hypofractionation
2
Platinum
2
Liver Transplantation
2
Fluorodeoxyglucose F18
2
Floxuridine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
trifluridine tipiracil drug combination
×
90 days
×
Clear all
No trials found.